These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Association between elevated red blood cell distribution width and long-term mortality in acute pulmonary embolism.
    Author: Kheirkham-Sabetghadam S, Jenab Y, Ghoreyshi-Hefzabad SM, Gohari-Moghadam K, Lotfi-Tokaldany M, Jalali A, Pourjafari M, Shirani S, Sotoudeh Anvari M, Etesamifar N.
    Journal: Turk J Med Sci; 2018 Apr 30; 48(2):318-323. PubMed ID: 29714446.
    Abstract:
    Background/aim: The prognostic value of the red cell distribution width (RDW) as a cost-effective and noninvasive test in acute pulmonary embolism (PE) is still unknown. We aimed to investigate the prognostic value of the admission RDW level in the long-term survival of PE patients. Materials and methods: In this registry-based, prospective cohort study, a total of 378 patients (mean age: 60.4 ± 17.11 years, 47.4% female) who presented with acute PE were enrolled. All the clinical data for each patient were obtained from our institutional PE registry. The follow-up was performed at a median time of 17 months. The primary endpoint was death at follow-up. Results: The mean RDW in study patients was 14.67 ± 2.13. The all-cause mortality rate during the follow-up was 15.6% (n = 59). After adjustment for potential confounders, the relationship between RDW and long-term mortality showed a trend of a significant level (hazard ratio: 1.109; 95% CI, 0.998−1.232; P = 0.053). We divided patients into 3 groups based on the European Society of Cardiology’s classification. As we moved from the low risk to the higher risk categories, the mean RDW increased significantly (P = 0.037). Conclusion: It seems there may be an independent association between RDW at presentation and PE mortality within 17 months.
    [Abstract] [Full Text] [Related] [New Search]